218 related articles for article (PubMed ID: 28029502)
1. Ovarian cancer in pregnancy.
Fruscio R; de Haan J; Van Calsteren K; Verheecke M; Mhallem M; Amant F
Best Pract Res Clin Obstet Gynaecol; 2017 May; 41():108-117. PubMed ID: 28029502
[TBL] [Abstract][Full Text] [Related]
2. Paclitaxel and carboplatin chemotherapy administered during pregnancy for advanced epithelial ovarian cancer.
Méndez LE; Mueller A; Salom E; González-Quintero VH
Obstet Gynecol; 2003 Nov; 102(5 Pt 2):1200-2. PubMed ID: 14607056
[TBL] [Abstract][Full Text] [Related]
3. Chemotherapy for ovarian cancer: an evidence-based approach.
Geisler JP; Manahan KJ; Wiemann MC
Minerva Ginecol; 2004 Dec; 56(6):539-45. PubMed ID: 15729206
[TBL] [Abstract][Full Text] [Related]
4. Neoadjuvant chemotherapy followed by interval cytoreductive surgery in patients with unresectable, advanced stage epithelial ovarian cancer: a single centre experience.
Bilici A; Salepci T; Dane F; Gumus M; Ustaalioglu BB; Seker M; Salman T; Turan C; Unal O; Yaylaci M
Arch Gynecol Obstet; 2010 Oct; 282(4):417-25. PubMed ID: 20035339
[TBL] [Abstract][Full Text] [Related]
5. Novel directions in adjuvant chemotherapy for early stage epithelial ovarian cancer.
Sakarya DK; Yetimalar MH; Ozbasar D
Asian Pac J Cancer Prev; 2015; 16(10):4157-60. PubMed ID: 26028065
[TBL] [Abstract][Full Text] [Related]
6. Prognostic factors for early-stage epithelial ovarian cancer, treated with adjuvant carboplatin/paclitaxel chemotherapy: a single institution experience.
Bamias A; Karadimou A; Soupos N; Sotiropoulou M; Zagouri F; Haidopoulos D; Thomakos N; Rodolakis A; Antsaklis A; Dimopoulos MA
Gynecol Oncol; 2011 Oct; 123(1):37-42. PubMed ID: 21764430
[TBL] [Abstract][Full Text] [Related]
7. Neoadjuvant chemotherapy (NACT) is an effective way of managing elderly women with advanced stage ovarian cancer (FIGO Stage IIIC and IV).
Glasgow MA; Yu H; Rutherford TJ; Azodi M; Silasi DA; Santin AD; Schwartz PE
J Surg Oncol; 2013 Feb; 107(2):195-200. PubMed ID: 22648987
[TBL] [Abstract][Full Text] [Related]
8. Paclitaxel with carboplatin versus paclitaxel with carboplatin alternating with cisplatin as first-line chemotherapy in advanced epithelial ovarian cancer: preliminary results of a Hellenic Cooperative Oncology Group study.
Skarlos DV; Aravantinos G; Kosmidis P; Athanassiadis A; Stathopoulos GP; Pavlidis N; Bafaloukos D; Karphathios S; Papakostas P; Bamia C; Fountzilas G
Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-57-S15-61. PubMed ID: 9346224
[TBL] [Abstract][Full Text] [Related]
9. [Effect of evidence-based medicine on the decision of chemotherapy for epithelial ovarian cancer].
Li GT
Zhonghua Fu Chan Ke Za Zhi; 2012 Aug; 47(8):582-6. PubMed ID: 23141177
[No Abstract] [Full Text] [Related]
10. Is perioperative visual estimation of intra-abdominal tumor spread reliable in ovarian cancer surgery after neoadjuvant chemotherapy?
Hynninen J; Lavonius M; Oksa S; Grénman S; Carpén O; Auranen A
Gynecol Oncol; 2013 Feb; 128(2):229-32. PubMed ID: 23142076
[TBL] [Abstract][Full Text] [Related]
11. Paclitaxel and carboplatin treatment for advanced ovarian cancer during pregnancy.
Ruiz Ramos J; Roma E; Palomar L; Poveda JL
Chemotherapy; 2013; 59(5):344-5. PubMed ID: 24820861
[TBL] [Abstract][Full Text] [Related]
12. Perioperative and clinical outcomes in the management of epithelial ovarian cancer using a robotic or abdominal approach.
Feuer GA; Lakhi N; Barker J; Salmieri S; Burrell M
Gynecol Oncol; 2013 Dec; 131(3):520-4. PubMed ID: 24080421
[TBL] [Abstract][Full Text] [Related]
13. Neoadjuvant chemotherapy followed by post-partum chemoradiotherapy and chemoconsolidation for stage IIIB glassy cell cervical carcinoma during pregnancy.
Seamon LG; Downey GO; Harrison CR; Doss B; Carlson JW
Gynecol Oncol; 2009 Sep; 114(3):540-1. PubMed ID: 19523669
[No Abstract] [Full Text] [Related]
14. Sorafenib in combination with carboplatin and paclitaxel as neoadjuvant chemotherapy in patients with advanced ovarian cancer.
Pölcher M; Eckhardt M; Coch C; Wolfgarten M; Kübler K; Hartmann G; Kuhn W; Rudlowski C
Cancer Chemother Pharmacol; 2010 May; 66(1):203-7. PubMed ID: 20204367
[TBL] [Abstract][Full Text] [Related]
15. Predictive markers of chemoresistance in advanced stages epithelial ovarian carcinoma.
Bonneau C; Rouzier R; Geyl C; Cortez A; Castela M; Lis R; Daraï E; Touboul C
Gynecol Oncol; 2015 Jan; 136(1):112-20. PubMed ID: 25449309
[TBL] [Abstract][Full Text] [Related]
16. In vitro fertilization in a patient with ovarian cancer (stage IC) following conservative surgery and chemotherapy: a case report.
Abu-Musa A; Seoud M; Hannoun A
Eur J Gynaecol Oncol; 2008; 29(4):408-10. PubMed ID: 18714583
[TBL] [Abstract][Full Text] [Related]
17. [Chemotherapy in epithelial ovarian cancer].
Tazi Y; Pautier P; Leary A; Lhomme C
Gynecol Obstet Fertil; 2013 Oct; 41(10):611-6. PubMed ID: 24094667
[TBL] [Abstract][Full Text] [Related]
18. Optimal primary therapy of ovarian cancer.
Bookman MA
Ann Oncol; 2016 Apr; 27 Suppl 1():i58-i62. PubMed ID: 27141074
[TBL] [Abstract][Full Text] [Related]
19. Kinase-driven metabolic signalling as a predictor of response to carboplatin-paclitaxel adjuvant treatment in advanced ovarian cancers.
Sereni MI; Baldelli E; Gambara G; Ravaggi A; Hodge KA; Alberts DS; Guillen-Rodriguez JM; Dong T; Memo M; Odicino F; Angioli R; Liotta LA; Pecorelli SL; Petricoin EF; Pierobon M
Br J Cancer; 2017 Aug; 117(4):494-502. PubMed ID: 28664915
[TBL] [Abstract][Full Text] [Related]
20. Neoadjuvant Chemotherapy in Advanced Ovarian Cancer: A Single-Institution Experience and a Review of the Literature.
Loizzi V; Leone L; Camporeale A; Resta L; Selvaggi L; Cicinelli E; Cormio G
Oncology; 2016; 91(4):211-216. PubMed ID: 27487241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
